Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
;
: 921-930, 2015.
Article
in English
| WPRIM
| ID: wpr-90546
ABSTRACT
PURPOSE:
The purpose of this study was to evaluate whether an exogenous epidermal growth factor (EGF) could induce anti-tumor and radiosensitizing effects in vivo. MATERIALS ANDMETHODS:
BALB/c-nu mice that were inoculated with A431 (human squamous cell carcinoma) cells in the right hind legs were divided into five groups I (no treatment), II (EGF for 6 days), III (EGF for 20 days), IV (radiotherapy [RT]), and V (RT plus concomitant EGF). EGF was administered intraperitoneally (5 mg/kg) once a day and the RT dose was 30 Gy in six fractions. Hematoxylin and eosin (H&E) stained sections of tumor, liver, lung, and kidney tissues were investigated. Additionally, tumors were subjected to immunohistochemistry staining with caspase-3.RESULTS:
EGF for 6 days decreased tumor volume, but it approached the level of the control group at the end of follow-up (p=0.550). The duration of tumor shrinkage was prolonged in group V while the slope of tumor re-growth phase was steeper in group IV (p=0.034). EGF for 20 days decreased tumor volume until the end of the observation period (p < 0.001). Immunohistochemistry revealed that mice in group V showed stronger intensity than those in group IV. There were no abnormal histological findings upon H&E staining of the normal organs.CONCLUSION:
EGF-induced anti-tumor effect was ascertained in the xenograft mouse models with A431 cells. Concomitant use of EGF has the potential role as a radiosensitizer in the design of fractionated irradiation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Radiation-Sensitizing Agents
/
Immunohistochemistry
/
Follow-Up Studies
/
Apoptosis
/
Eosine Yellowish-(YS)
/
Xenograft Model Antitumor Assays
/
Tumor Burden
/
Epidermal Growth Factor
/
Caspase 3
/
Heterografts
Type of study:
Observational study
/
Prognostic study
/
Risk factors
Limits:
Animals
Language:
English
Journal:
Cancer Research and Treatment
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS